Table 1.
Study, Species (Number of Isolates Tested) |
Isavuconazole | Voriconazole | Posaconazole | |||
---|---|---|---|---|---|---|
MIC50, MIC90 |
ECOFF/R Breakpoint According to EUCAST v. 10.0 2020 |
MIC50, MIC90 |
ECOFF/R Breakpoint According to EUCAST v. 10.0 2020 |
MIC50, MIC90 |
ECOFF/R Breakpoint According to EUCAST v. 10.0 2020 |
|
Pfaller et al., 2021 [23] | ||||||
A. fumigatus ISA (n = 70), VORI (n = 189), POSA (n = 189) |
0.5, 1 | 2/>2 | 0.5, 0.5 | 1/>1 | 0.25, 0.5 | 0.25/>0.25 |
A. flavus ISA (n = 19), VORI (n = 43), POSA (n = 43) |
0.5, 1 | 2/>2 | 0.5, 1 | 2/- | 0.25, 0.5 | 0.5/- |
A. niger ISA (n = 18), VORI (n = 46), POSA (n = 46) |
0.5, 4 | 4/- | 1, 1 | 2/- | 0.5, 1 | 0.5/- |
A. terreus ISA (n = 6), VORI (n = 14), POSA (n = 14) |
2, ND | 1/>2 | 0.25, 0.25 | 2/- | 0.25, 0.25 | 0.25/>0.25 |
A. nidulans ISA (n = 6), VORI (n = 11), POSA (n = 11) |
0.03, ND | 0.25/>0.25 | 0.12, 0.25 | 1/>1 | 0.25, 0.5 | 0.5/- |
Astvad et al., 2017 [22] | ||||||
A. fumigatus (n = 211) |
1, ND | 2/>2 | 0.5, ND | 1/>1 | ND | 0.25 > 0.25 |
A. niger (n = 41) |
2, ND | 4/- | 1, ND | 2/- | ND | 0.5/ND |
A. terreus species complex (n = 27) |
1, ND | 1/>2 | 1, ND | 2/- | ND | 0.25/>0.25 |
A. flavus species complex (n = 19) |
1, ND | 2/>2 | 1, ND | 2/- | ND | 0.5/- |
Abbreviations: ECOFFs, epidemiologic cut-off value; EUCAST, European Committee on Antimicrobial Susceptibility Testing; MIC50, Minimum Inhibitory Concentration required to inhibit the growth of 50% of organisms; MIC90, Minimum Inhibitory Concentration required to inhibit the growth of 90% of organisms; ISA, isavuconazole; ND, no data; POSA, posaconazole; VORI, voriconazole; -, not defined.